Intensity Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing an approach to treat solid tumor cancers. It leverages its DfuseRx technology platform to create proprietary drug formulations. Its product c... اقرأ أكثر
احصل على تحليلات مفصلة للأسهم من LSEG تتضمن السعر المستهدف بحسب رأي المحللين.